Impact of a Digital Inhalation Coach on Inhalation Errors and Asthma Control

<b><i>Background:</i></b> Inhalation errors are a common source of underdosing in asthma therapy, leading to poor asthma control. Therefore, regular inhalation training is recommended. The Kata® app is a digital inhalation coach that provides step-by-step guidance on how to inhale effectively. This analysis evaluated the effect of the app on inhalation technique and clinical endpoints (fractional exhaled nitric oxide [FeNO]; Asthma Control Questionnaire [ACQ-5]) in a clinical trial. <b><i>Methods:</i></b> This <i>post hoc</i> analysis of app data collected during a phase-II randomized controlled trial, included adult patients with moderate-to-severe, uncontrolled type-2 high asthma (<i>N</i> = 78). A smartphone with the study-specific app version was provided and patients' usual asthma maintenance treatment entered. Inhalations were video recorded whenever the inhalation coach was used. Inhalation errors were scored by trained experts according to predefined criteria. Rates for total and critical errors (significantly affecting drug delivery) were calculated as the number of errors per inhalation. Analysis of clinical endpoints used data from the run-in phase only to avoid interference with study interventions. <b><i>Results:</i></b> Univariate regression analysis showed a significant decrease of the total error rate of 1.4% per study day (<i>p</i> < 0.001; 95% CI: 0.8-1.9) and of the critical error rate (1.8% per study day; <i>p</i> < 0.001; 95% CI: 1.0-2.6). A significant reduction of the ACQ-5 score was found for the run-in phase (<i>p</i> = 0.036; <i>N</i> = 59). The mean (SD) ACQ-5 change (V2-V0) was -0.2 (0.7), reflecting a small improvement of asthma control. A clinically relevant improvement of the ACQ-5 score was found in 18 of 59 patients (31%). No significant improvement of FeNO was found (<i>p</i> = 0.170; <i>N</i> = 60). However, 26 of 60 patients (43%) showed a clinically relevant decrease (>20%) of FeNO. <b><i>Conclusions:</i></b> The Kata app improved inhalation technique and this was accompanied by a small improvement of asthma control. The Kata app is a useful tool for patients using inhalers to treat their asthma.

Authors

Institutions

Publication Details

Journal
Journal of Aerosol Medicine and Pulmonary Drug Delivery
Published
2025-12-23
DOI
https://doi.org/10.1177/19412711251370277
Primary Topic
Inhalation and Respiratory Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of a Digital Inhalation Coach on Inhalation Errors and Asthma Control

Philipp Kroneberg, Laura J. Arendsen, Sabine Häußermann, Marion Wencker et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
Inhalation and Respiratory Drug Delivery
article

Impact of a Digital Inhalation Coach on Inhalation Errors and Asthma Control

Philipp Kroneberg, Laura J. Arendsen, Sabine Häußermann, Marion Wencker, Michael Meyer, Kai M. Beeh
article en

Abstract

<b><i>Background:</i></b> Inhalation errors are a common source of underdosing in asthma therapy, leading to poor asthma control. Therefore, regular inhalation training is recommended. The Kata® app is a digital inhalation coach that provides step-by-step guidance on how to inhale effectively. This analysis evaluated the effect of the app on inhalation technique and clinical endpoints (fractional exhaled nitric oxide [FeNO]; Asthma Control Questionnaire [ACQ-5]) in a clinical trial. <b><i>Methods:</i></b> This <i>post hoc</i> analysis of app data collected during a phase-II randomized controlled trial, included adult patients with moderate-to-severe, uncontrolled type-2 high asthma (<i>N</i> = 78). A smartphone with the study-specific app version was provided and patients' usual asthma maintenance treatment entered. Inhalations were video recorded whenever the inhalation coach was used. Inhalation errors were scored by trained experts according to predefined criteria. Rates for total and critical errors (significantly affecting drug delivery) were calculated as the number of errors per inhalation. Analysis of clinical endpoints used data from the run-in phase only to avoid interference with study interventions. <b><i>Results:</i></b> Univariate regression analysis showed a significant decrease of the total error rate of 1.4% per study day (<i>p</i> < 0.001; 95% CI: 0.8-1.9) and of the critical error rate (1.8% per study day; <i>p</i> < 0.001; 95% CI: 1.0-2.6). A significant reduction of the ACQ-5 score was found for the run-in phase (<i>p</i> = 0.036; <i>N</i> = 59). The mean (SD) ACQ-5 change (V2-V0) was -0.2 (0.7), reflecting a small improvement of asthma control. A clinically relevant improvement of the ACQ-5 score was found in 18 of 59 patients (31%). No significant improvement of FeNO was found (<i>p</i> = 0.170; <i>N</i> = 60). However, 26 of 60 patients (43%) showed a clinically relevant decrease (>20%) of FeNO. <b><i>Conclusions:</i></b> The Kata app improved inhalation technique and this was accompanied by a small improvement of asthma control. The Kata app is a useful tool for patients using inhalers to treat their asthma.

Journal of Aerosol Medicine and Pulmonary Drug Delivery
Respiratory Research Institute (DE), Sterna Biologicals (Germany) (DE)
Good health and well-being
Openalex Percentile: Top 29%
Inhalation and Respiratory Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.